Between February 1995 and September 2004, 47 patients (53 lesions) with primary ocular adnexal MALT lymphoma were treated with radiotherapy. The median dose delivered was 30Gy/20F. Lens shielding was used in 11 patients. Local control rate was 98%. 3, 5 years OAS (overall survival) and RFS (relapse-free survival) were 100%. 100% and 100%, 88%. respectively. Cataracts developed in 17%. Radiotherapy achieved excellent local control and survival rates in the management of primary ocular adnexal MALT lymphoma. Late adverse effects were tolerable.
|Number of pages||4|
|Journal||Japanese Journal of Clinical Radiology|
|Publication status||Published - Dec 1 2005|
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging